日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Inhaled vaccine shows signs of promise

By WANG XIAOYU | CHINA DAILY | Updated: 2021-07-29 09:08
Share
Share - WeChat
A worker takes a jab of COVID-19 vaccine in Nanjing, East China's Jiangsu province on June 8, 2021. [Photo/Xinhua]

A two-dose inhaled COVID-19 vaccine developed by Chinese researchers appears to be safe and capable of eliciting strong immune responses comparable to those of its one-dose injected counterpart, a preliminary study released this week said.

Cansino Biologics, which created the vaccine with the Academy of Military Medical Sciences' Beijing Institute of Biotechnology, said it is the first company in the world to publish clinical data on an aerosol COVID-19 vaccine.

Results from its early stage human trial are promising and support further research into what promises to be an effective and economical candidate, it said.

The company's injectable COVID-19 vaccine gained conditional approval from the top drug regulator in late February, and the new version is identical in terms of composition, packaging and manufacturing process, except that it is delivered through inhalation and contains a lower dosage-about one-fifth that of the injection.

The study's results were published in The Lancet Infectious Disease, based in the United Kingdom, on Monday. It recruited 130 volunteers aged 18 or older in late September. They were given five different vaccine combinations that varied in dosage and delivery method.

The results show that the inhaled vaccine, known as aerosolized Ad5-nCoV, was well tolerated, with no severe adverse reactions reported. The most common symptoms included fever, fatigue and headache.

The study said the proportion of participants reporting adverse reactions was markedly higher among those who received injections than among those in the inhalation group.

In terms of efficacy, the study said one dose of the inhaled vaccine could induce a strong immune response, and after two doses, it "could produce similar SARS-CoV-2 neutralizing antibody titers (concentrations) as one dose of intramuscular vaccination".

The study also looked into the effects of first administering an injection and then delivering the second dose through inhalation as a booster, which also triggered robust antibody responses.

"In conclusion, the aerosol inhalation of Ad5-nCoV is painless, simple, well tolerated, and immunogenic, and the current data support the evaluation of aerosolized Ad5-nCoV in ongoing phase 2 and 3 clinical trials," the study said. It added that the study was limited in that the sample size was relatively small.

No inhaled COVID-19 vaccines have been approved for use, but researchers around the world have stepped up research due to their potentially unique strengths.

Hou Lihua, a researcher at the institute, told China Central Television that the new vaccine could potentially increase the willingness of the public to get vaccinated because of the lower rates of adverse events.

The product's lower dosage could also relieve some pressure on production capacity, he said, adding that the inhalation method also obviates concerns about medical waste such as syringe needles.

Yu Xuefeng, chairman and CEO of Cansino, said in an earlier interview that in addition to humoral and cellular immune responses-protections triggered by regular injected vaccines-inhaled vaccines can induce an extra layer of protection known as mucosal immunity.

"Because the novel coronavirus usually invades human bodies through the respiratory mucosa, setting up the first defense against the virus at its inception point will generate good protective effects," he said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美视屏一区二区 | 日韩精品一区二区在线观看 | 国产成人精品免费午夜 | 亚洲 欧美 激情 小说 另类 | 久久在线中文字幕 | 成人欧美日韩视频一区 | 亚洲成a人在线观看 | 成人欧美一区二区三区黑人3p | 久久亚洲精品玖玖玖玖 | 18性夜影院午夜寂寞影院免费 | 国产福利在线观看精品 | 91看片免费看 | 久久国产精品免费一区二区三区 | 成人精品鲁一区一区二区 | 黄色三级在线观看 | 国产亚洲蜜芽精品久久 | 在线中文视频 | 日韩欧美不卡 | 日韩一区精品视频 | 看免费黄色大片 | 色婷婷社区| 欧美亚洲韩国国产综合五月天 | 男女视频免费在线观看 | 九九综合九九 | 亚洲人人爱 | 国产高清网址 | 久久久一区二区三区精品 | 亚洲欧美一区二区三区在线 | 欧美日色 | 天堂最新在线资源 | 男女午夜性爽快免费视频不卡 | 亚洲成人一区 | 日韩欧美在线一区 | 黑人插插 | 18sexvideo| 亚洲二区视频 | 青娱分类视频精品免费2 | 日韩精品在线一区二区 | 深夜你懂的在线网址入口 | 中文字幕日本视频 | 免费在线观看的毛片 |